Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Rhea-AI Summary
Zimmer Biomet (NYSE:ZBH) announced that its management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8. A fireside chat is scheduled for 10:40 a.m. ET, with a live audio webcast and replay available on the company’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – ZBH
In the Jun 2 session, ZBH gained 0.98%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 22 | Quarterly dividend | Positive | -1.3% | Board approved a $0.24 Q2 2026 cash dividend. |
| May 12 | Buyback increase | Positive | +4.8% | Raised 2026 share repurchase expectations to up to $1 billion. |
| May 06 | Conference appearance | Neutral | -0.2% | Announced BofA conference fireside chat with webcast access. |
| Apr 28 | Q1 2026 earnings | Positive | -10.6% | Reported higher Q1 sales, earnings, cash flow, and raised 2026 guidance. |
| Apr 28 | CFO transition | Negative | -10.6% | Announced CFO departure and appointment of an interim CFO. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows mixed reactions: buyback and dividend actions saw modest moves, while strong Q1 results coincided with a sharp decline, indicating occasional negative reactions to otherwise positive fundamentals.
Over the last few months, Zimmer Biomet reported strong Q1 2026 results with net sales of $2.087 billion and higher adjusted EPS, alongside raised 2026 EPS and free cash flow expectations. Despite this, shares fell about 10.57%. The company also announced a CFO transition on Apr 28, coinciding with that drop. Subsequent capital allocation updates included a quarterly dividend of $0.24 per share and plans to repurchase up to $1 billion of stock under a $1.5 billion authorization. Today’s conference participation follows recent investor-focused communications.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., June 2, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
Media Troy Kirkpatrick 614-284-1926 troy.kirkpatrick@zimmerbiomet.com
Kirsten Fallon 781-779-5561 | Investors David DeMartino 646-531-6115 david.demartino@zimmerbiomet.com
Zach Weiner 908-591-6955 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302787549.html
SOURCE Zimmer Biomet Holdings, Inc.